Skip to main content
SpringerLink
Log in

Compliance, quality of life, and cost effectiveness

  • Clinical Trials Review
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Burt VL, Whelton P, Roccella EJ, et al.: Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey 1988–1991 (NHANES III). Hypertension 1995, 25:305–313.

    PubMed  CAS  Google Scholar 

  2. Jackson R: What are the implications for the communit of the discrepancy between the theory and practice of BP control? J Hum Hypertens 1995; 9(suppl 2):25–28.

    Google Scholar 

  3. Mancia G, Sega R, Milesi C, et al.: Blood pressure control in the hypertensive population. Lancet 1997, 349:454–457.

    Article  PubMed  CAS  Google Scholar 

  4. Coca A: Actual blood pressure control: are we doing things right? J Hypertens 1998, 16(suppl 1):45–51.

    Google Scholar 

  5. Rizzo JA, Simons WR: Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997, 19(6):1446–1457.

    Article  PubMed  CAS  Google Scholar 

  6. Caro JJ, Speckman JL, Salas M, et al.: Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Can Med Assoc J 1999, 160:41–46.

    CAS  Google Scholar 

  7. Applegate WB: Quality of life during antihypertensive treatment: lessons from the Systolic Hypertension in the Elderly Program. Am J Hypertens 1998, 11:57S-61S.

    Article  PubMed  CAS  Google Scholar 

  8. Applegate WB, Pressel S, Wittes J, et al.: Impact of the treatment of isolated systolic hypertension on behavioral variables. Arch Intern Med 1994, 154:2154–2160.

    Article  PubMed  CAS  Google Scholar 

  9. Plaisted CS, Lin PH, Ard JD, et al.: The effects of dietary patterns on quality of life: a substudy of the Dietary Approaches to Stop Hypertension trial. J Am Diet Assoc 1999, 99(suppl 8):84–89.

    Article  Google Scholar 

  10. Hunt SM: Quality of life claims in trials of anti-hypertensive therapy. Qual Life Res 1997, 6(2):185–191.

    Article  PubMed  CAS  Google Scholar 

  11. Testa MA, Lenderking WR: Interpreting pharmacoeconomic and quality of life clinical trial data for use in therapeutics. Pharmacoeconomics 1992, 2(2):107–117.

    Article  PubMed  CAS  Google Scholar 

  12. Edelson JT, Weinstein MC, Tosteson AN, et al.: Long-term cost-effectiveness of various initial monotherapies for mild tp moderate hypertension. JAMA 1990, 263:407–413.

    Article  PubMed  CAS  Google Scholar 

  13. Weir MR: The rationale for combination versus single-entity therapy in hypertension. Am J Hypertens 1998, 11:163S-169S.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 29 Sandy Pond Road, 01773, Lincoln, MA, USA

    William B. Stason MD, MSc

Authors
  1. William B. Stason MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stason, W.B. Compliance, quality of life, and cost effectiveness. Curr Hypertens Rep 1, 471–474 (1999). https://doi.org/10.1007/s11906-996-0017-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-996-0017-8

Keywords

Search

Navigation